What Does Wall Street Think About Merck & Co. (MRK)?

Merck & Co., Inc. (NYSE:MRK) is one of the best medical stocks to buy now. On September 26, Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Co., Inc. (NYSE:MRK). Similarly, Roth MKM also assigned a Hold rating to the stock on September 17 with a $90 price target. How Merck & Co. (MRK) Turns Robust Free Cash Flow Into Shareholder Value In another report released on September 16, Berenberg Bank also downgraded Merck & Co., Inc. (NYSE:MRK) to a Hold, bringing the price target down to $9 ...